Parent-determined Oral Montelukast Therapy for Preschool Wheeze With Stratification for Arachidonate-5-Lipoxygenase (ALOX5) Promoter Genotype.
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2014
At a glance
- Drugs Montelukast (Primary)
- Indications Wheezing
- Focus Therapeutic Use
- Acronyms WAIT
- 22 Apr 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 24 Nov 2012 Accrual to date is 105% according to United Kingdom Clinical Research Network.
- 20 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.